Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reunion Neuroscience Inc. - Common Shares (NQ: REUN )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.110 (83)
Ask (Size) 1.130 (15)
Prev. Close 1.120
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference
From Reunion Neuroscience Inc.
Via GlobeNewswire
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published 
Via Benzinga

Performance

More News

Read More
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Via Benzinga
Recap: Reunion Neuroscience Q4 Earnings
Via Benzinga
Reunion Neuroscience: Q4 Earnings Insights
Via Benzinga
What's Going On With Reunion Neuroscience Stock Today
Via Benzinga
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Via Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
Via Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
Via Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
Via Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
Via Benzinga
The 7 Most Promising Penny Stocks to Buy in June
Via InvestorPlace
Psyched: Millions From Institutional Investor And Fed Funding For Research, M&As, Women Veterans And More
Via Benzinga
Traders Insights: Stocks Making Moves After Announcing News: REUN, WLDS, SPRC, QBTS
Via AB Newswire
Reunion Neuroscience Announces $13.1M Take-Private Transaction With Biotech Investment Firm
Via Benzinga
Nasdaq Surges Over 1%; Dollar General Lowers Annual Guidance
Via Benzinga
Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
US Stocks Turn Higher; ISM Manufacturing PMI Drops In May
Via Benzinga
REUN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Reunion Neuroscience Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
Via Benzinga
Reunion Neuroscience Enters Compliance Period, Struggles To Remain NASDAQ Listed
Via Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Via Benzinga
Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.